Prevalence of amyloid in ligamentum flavum of patients with lumbar spinal stenosis

References

• Benson MD, Buxbaum JN, Eisenberg DS, et al. Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee. Amyloid. 2020;27(4):217–222. doi: 10.1080/13506129.2020.1835263.
   PubMed Web of Science ®Google Scholar
• Sueyoshi T, Ueda M, Jono H, et al. Wild-type transthyretin-derived amyloidosis in various ligaments and tendons. Hum Pathol. 2011;42(9):1259–1264. doi: 10.1016/j.humpath.2010.11.017.
   PubMed Web of Science ®Google Scholar
• Solomon A. Management of AL amyloidosis in 2021+. Amyloid. 2022;29(1):66. doi: 10.1080/13506129.2021.1974831.
   PubMed Web of Science ®Google Scholar
• Rahel S, Flammer Andreas J, Sabine G, et al. Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis. Swiss Med Wkly. 2020;150:w20364.
   PubMed Web of Science ®Google Scholar
• Gilstrap LG, Dominici F, Wang Y, et al. Epidemiology of cardiac amyloidosis-associated heart failure hospitalizations among fee-for-service Medicare beneficiaries in the United States. Circ Hear Fail. 2019;12:e005407.
   PubMed Web of Science ®Google Scholar
• Maurer MS, Bokhari S, Damy T, et al. Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis. Circ Heart Fail. 2019;12(9):e006075. doi: 10.1161/CIRCHEARTFAILURE.119.006075.
   PubMed Web of Science ®Google Scholar
• Aus Dem Siepen F, Hein S, Prestel S, et al. Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy? Clin Res Cardiol. 2019;108(12):1324–1330. doi: 10.1007/s00392-019-01467-1.
   PubMed Web of Science ®Google Scholar
• Westin O, Fosbøl EL, Maurer MS, et al. Screening for cardiac amyloidosis 5 to 15 years after surgery for bilateral carpal tunnel syndrome. J Am Coll Cardiol. 2022;80(10):967–977. doi: 10.1016/j.jacc.2022.06.026.
   PubMed Web of Science ®Google Scholar
• Sperry BW, Reyes BA, Ikram A, et al. Tenosynovial and cardiac amyloidosis in patients undergoing carpal tunnel release. J Am Coll Cardiol. 2018;72(17):2040–2050. doi: 10.1016/j.jacc.2018.07.092.
   PubMed Web of Science ®Google Scholar
• Maurer MS, Schwartz JH, Gundapaneni B, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018;379(11):1007–1016. doi: 10.1056/NEJMoa1805689.
   PubMed Web of Science ®Google Scholar
• APOLLO-B. A study to evaluate patisiran in participants with transthyretin amyloidosis with cardiomyopathy (ATTR amyloidosis with cardiomyopathy). ClinicalTrials.gov; 2022 [cited 2022 Oct 21]. Available from: https://clinicaltrials.gov/ct2/show/NCT03997383
   Google Scholar
• Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem. 1962;10(3):355–364. doi: 10.1177/10.3.355.
   Web of Science ®Google Scholar
• Hahn K, Nilsson KPR, Hammarström P, et al. Establishing and validating the fluorescent amyloid ligand h-FTAA (heptamer formyl thiophene acetic acid) to identify transthyretin amyloid deposits in carpal tunnel syndrome. Amyloid. 2017;24(2):78–86. doi: 10.1080/13506129.2017.1316711.
   PubMed Web of Science ®Google Scholar
• Lux A, Gottwald J, Behrens HM, et al. Complement 9 in amyloid deposits. Amyloid. 2021;28(3):199–208. doi: 10.1080/13506129.2021.1932799.
   PubMed Web of Science ®Google Scholar
• Sakamaki T, Sairyo K, Sakai T, et al. Measurements of ligamentum flavum thickening at lumbar spine using MRI. Arch Orthop Trauma Surg. 2009;129(10):1415–1419. doi: 10.1007/s00402-009-0849-1.
   PubMed Web of Science ®Google Scholar
• Bender R, Lange S. Adjusting for multiple testing – when and how? J Clin Epidemiol. 2001;54(4):343–349. doi: 10.1016/s0895-4356(00)00314-0.
   PubMed Web of Science ®Google Scholar
• D'Agostino AN, Mason MS, Quinn SF. Lumbar spinal stenosis and spondylosis associated with amyloid deposition in the ligamentum flavum. Clin Neuropathol. 1992;11(3):147–150.
   PubMed Web of Science ®Google Scholar
• Westermark P, Westermark GT, Suhr OB, et al. Transthyretin-derived amyloidosis: probably a common cause of lumbar spinal stenosis. Ups J Med Sci. 2014;119(3):223–228. doi: 10.3109/03009734.2014.895786.
   PubMed Web of Science ®Google Scholar
• Yanagisawa A, Ueda M, Sueyoshi T, et al. Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis. Mod Pathol. 2015;28(2):201–207. doi: 10.1038/modpathol.2014.102.
   PubMed Web of Science ®Google Scholar
• Benson MD, Berk JL, Dispenzieri A, et al. Tissue biopsy for the diagnosis of amyloidosis: experience from some centres. Amyloid. 2022;29(1):8–13. doi: 10.1080/13506129.2021.1994386.
   PubMed Web of Science ®Google Scholar
• George KM, Hernandez NS, Breton J, et al. Increased thickness of lumbar spine ligamentum flavum in wild-type transthyretin amyloidosis. J Clin Neurosci. 2021;84:33–37. doi: 10.1016/j.jocn.2020.11.029.
   PubMed Web of Science ®Google Scholar
• Wang AY, Saini H, Tingen JN, et al. The relationship between wild-type transthyretin amyloid load and ligamentum flavum thickness in lumbar stenosis patients. World Neurosurg. 2022;164:e113–e118. doi: 10.1016/j.wneu.2022.04.008.
   PubMed Web of Science ®Google Scholar
• Eldhagen P, Berg S, Lund LH, et al. Transthyretin amyloid deposits in lumbar spinal stenosis and assessment of signs of systemic amyloidosis. J Intern Med. 2021;289(6):895–905. doi: 10.1111/joim.13222.
   PubMed Web of Science ®Google Scholar
• Godara A, Riesenburger RI, Zhang DX, et al. Association between spinal stenosis and wild-type ATTR amyloidosis. Amyloid. 2021;28(4):226–233. doi: 10.1080/13506129.2021.1950681.
   PubMed Web of Science ®Google Scholar
• George KM, Dowd RS, Nail J, et al. Wild-type transthyretin amyloidosis occurring in the ligamentum flavum of the cervicothoracic spine. World Neurosurg. 2020;142:e325–e330. doi: 10.1016/j.wneu.2020.06.228.
   PubMed Web of Science ®Google Scholar
• Kroi F, Fischer N, Gezin A, et al. Estimating the gender distribution of patients with wild-type transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis. Cardiol Ther. 2021;10(1):41–55. doi: 10.1007/s40119-020-00205-3.
   PubMed Web of Science ®Google Scholar
• Campbell CM, LoRusso S, Dispenzieri A, et al. Sex differences in wild-type transthyretin amyloidosis: an analysis from the transthyretin amyloidosis outcomes survey (THAOS). Cardiol Ther. 2022;11(3):393–405. doi: 10.1007/s40119-022-00265-7.
   PubMed Web of Science ®Google Scholar
• Tasaki M, Okada M, Yanagisawa A, et al. Apolipoprotein AI amyloid deposits in the ligamentum flavum in patients with lumbar spinal canal stenosis. Amyloid. 2021;28(2):107–112. doi: 10.1080/13506129.2020.1858404.
   PubMed Web of Science ®Google Scholar
• Treitz C, Gottwald J, Gericke E, et al. Quantitative proteome profiling provides evidence of an activation of the complement cascade in ATTR amyloidosis. Amyloid. 2022;29(2):102–109. doi: 10.1080/13506129.2021.2015316.
   PubMed Web of Science ®Google Scholar
• Maurer MS, Smiley D, Simsolo E, et al. Analysis of lumbar spine stenosis specimens for identification of amyloid. J Am Geriatr Soc. 2022;70(12):3538–3548. doi: 10.1111/jgs.17976.
   PubMed Web of Science ®Google Scholar